15 min read
June 30, 2026
You came here for a number. Every guide gives you the same one — $30,000 to $500,000-plus — and it's accurate and almost useless, because it spans an order of magnitude for reasons nobody explains.
Custom healthcare software development cost typically runs from $30,000 for a simple HIPAA-aligned app to $2 million or more for a high-risk diagnostic tool requiring FDA clearance. Three variables move the number more than features do: how deep your compliance obligations run, how many clinical systems you integrate with, and your product's regulatory class.
The percentage everyone quotes — "HIPAA adds 15 to 25 percent" — hides the part that matters. Fifteen percent of what, and paid when? Build compliance in from the first commit and it's a design constraint. Retrofit it into a working product and the same requirement costs three to five times more. This article prices each driver, including the one no other cost guide covers: what your regulatory class does to the number.
Tell us what you're building. We'll give you a number you can defend to a board.
The honest healthcare software development cost range — and why it's almost useless alone
A simple, HIPAA-aligned application starts around $40,000 to $100,000. A mid-level platform with integrations and multiple user roles runs $80,000 to $250,000. An enterprise or AI-enabled system reaches $250,000 to $500,000 and beyond.
Those bands are real. They're also where most guides stop, which is why most guides don't help you. A custom healthcare software development cost spans an order of magnitude because the things inside it aren't optional features you can trade away. They're set by what your product is and who it answers to.
Three variables decide where you land, and this article prices each one: the depth of your compliance obligations, the scope of your clinical-system integrations, and your regulatory class. Features matter. They matter less than these three.
One correction before the numbers. There is no such thing as "HIPAA certified." HIPAA is not a credential a vendor hands you at the end of a build. It's an architecture — how you store PHI, who can reach it, what gets logged — and an ongoing program you run for the life of the product. The cost to build a healthcare app goes wrong the moment someone treats that program as a checkbox.
Why healthcare software costs more than the same app in any other industry
Build a scheduling app for a gym and a scheduling app for an oncology clinic. The second one costs more — sometimes several times more. The user-facing feature is identical. Everything underneath it is not.
Protected health information changes the engineering at the foundation. Every read and write of PHI needs access control tied to a role, an audit log that records who saw what and when, and encryption — at rest and in transit — that survives an auditor's inspection. None of this shows up in the UI. All of it is in scope from the first sprint.
The teams that get burned build the product first and add compliance later. Retrofitting HIPAA controls into a finished system costs three to five times what building them in would have. You're not adding a feature at that point. You're re-opening data models, rewriting access logic, and re-testing paths you thought were done.
Clinical-workflow validation is the other premium. Software that touches patient care has to be tested against how clinicians actually work, not how a product manager imagined they work. A multi-role permission system — where a nurse, a physician, and a billing administrator each see a different slice of the same record — is a real line item, not a config setting.
The premium isn't margin. It's the cost of software that can be trusted with a patient.
The cost drivers, priced
Here is the working budget: the three drivers that move a healthcare number most, with figures attached. These three lines are what drives the number in practice — not the feature list.
Compliance depth
The HIPAA compliant software development cost everyone quotes as "15 to 25 percent" is real, but the percentage is a trap if you read it as a constant. It's a percentage of a base you control. Fifteen percent of a clean, compliance-first build is a smaller absolute number than 25 percent of a sprawling retrofit — and the retrofit carries the 3-to-5x penalty on top.
HIPAA is also not the whole bill. SOC 2 Type II — which enterprise and payer customers increasingly require before they sign — adds an audit cycle and the controls to pass it. If your product is a regulated medical device, 21 CFR Part 11 governs electronic records and signatures and brings its own validation burden. These are separate obligations. They stack.
EHR and FHIR integration
A single EHR integration adds $50,000 to $150,000 and two to six months, independent of your product timeline. Treat that as a floor, not a quote.
"EHR integration" is not one price, and any vendor who quotes it as one is guessing. A read-only feed that pulls lab results is a different effort from bidirectional write-back that pushes orders into the clinician's system. The write-back path carries more risk, more testing, more liability.
HL7 FHIR has standardized the interface, not the effort. A common data model lowers the cost of a clean read integration, but mapping your product to a specific health system's FHIR implementation — and validating write-back against their rules — is still bespoke engineering per system.
There's also a wait you can't engineer around. Sandbox access to a major EHR has to be granted before your team can start, and Epic certification alone runs six to twelve weeks. That clock starts before the first line of integration code — and runs whether or not your engineers are busy.
Team geography
Rates vary by region: $80 to $150 an hour in the US and Western Europe, $40 to $70 in Eastern Europe, $20 to $40 in parts of India and Latin America. The offshore arithmetic is obvious, and it's a trap.
Two vendors can quote the same scope five times apart. The cheaper bid wins, then the rework arrives — failed reviews, missed compliance requirements, integration that doesn't hold — and the healthcare premium gets paid twice. The cheapest developer who has never shipped a regulated product is the most expensive way to learn what you didn't scope.
HIPAA architecture
15–25% of build
Built-in vs. retrofitted (3–5x)
PHI exposure, breach liability, failed audit
SOC 2 Type II
Audit cycle + controls
Enterprise / payer requirements
Deals stall at the security review
21 CFR Part 11
Added validation burden
Whether the product is a regulated device
Non-compliant e-records; submission rejected
EHR / FHIR integration
$50k–$150k each, 2–6 months
Read-only vs. write-back; sandbox wait
Integration that breaks in production
Team geography
$20–$150/hr
Regulated-healthcare experience
Rework that erases the savings several times over
What your regulatory class does to the number
Every healthcare software development pricing guide prices features. None of them prices the thing that moves a medical software development cost most: the regulatory pathway your product is on. If you're building a wellness tracker, this section won't change your number. If you're building anything that informs a clinical decision, it's the section that decides it.
Start with the frame. Whether your software is a medical device — Software as a Medical Device, or SaMD — depends on two things: how significant the information it provides is, and how critical the healthcare situation is. A tool that flags a possible stroke on a CT scan sits at the top of that grid. A tool that logs your step count sits at the bottom. That position drives your IEC 62304 software safety class — A, B, or C — which in turn dictates how much rigor your development lifecycle has to carry.
Three axes, not one. This is where budgets break:
IMDRF / SaMD risk class describes the clinical risk of the information your software provides.
FDA device class (I, II, III) describes the regulatory pathway in the United States.
IEC 62304 safety class (A, B, C) describes the engineering rigor your software lifecycle must meet.
They interact, but they are not the same axis. Conflating them is how teams under-scope by a factor that ends a project. A product can sit at a low FDA class and still carry serious IEC 62304 obligations. Settle all three before you budget — not after.
Two standards sit behind every rung above the wellness line. ISO 13485 is the quality management system your organization operates under; ISO 14971 is the risk-management process that decides which hazards you have to control and prove you controlled. Neither is a document you write once. They're the system your evidence lives in, and standing them up is a cost most first-time medtech budgets find late.
Here is the ladder the rest of the SERP doesn't publish.
Not a device (wellness / general health)
Information doesn't drive clinical decisions
HIPAA architecture only — standard build ranges
None beyond the build
Privacy and security documentation
Class I / IEC 62304 Class A
No injury possible if it fails
Class A MVP floor ~$250,000
Lightweight oversight
Risk file, basic V&V
Class II / 510(k)
Moderate risk; a predicate device exists
510(k) prep $50,000–$250,000 + FY2026 user fee ~$24,335
3–9 month FDA review
Full V&V, substantial-equivalence dossier
Class C / high-risk + clinical validation
Failure could cause serious injury or death
$2,000,000+
Clinical-study timelines
V&V, clinical evidence, design history file
Two costs in that table are easy to miss.
The first is evidence volume. Software verification and validation documentation for a submission runs 300 to 1,000 pages. The design history file and the traceability matrix — every requirement linked to its test and its risk control — are deliverables you build as you go, not paperwork you assemble at the end. Budget them as engineering, because that is what they are.
The second is change control. A 510(k) clearance covers a specific version of your software. Ship a new algorithm, a new indication, or a new patient population, and you can trigger a new submission — a recurring cost, not a one-time one. For AI/ML products that retrain, a Predetermined Change Control Plan lets you define in advance the changes you can make without re-clearing each model update. Designing that in early is a budget decision, not a regulatory afterthought.
One honest caveat. These rungs are directional. Classification drives everything above it, and it has to be settled in discovery — not assumed from a competitor's price page. The reason a build clears its audit is unglamorous: the classification work happens before the estimate, not after the rejection.
On budget, because there's no rework to absorb
The costs the quote doesn't show: total cost of ownership
The build price is the part everyone negotiates. It's also the smaller half. Over five years, healthcare software total cost of ownership reaches two to three times the initial build. Plan for the number you'll pay, not the number you sign.
Maintenance runs 15 to 20 percent of the build cost every year. In regulated healthcare that isn't only bug fixes — it's keeping pace with standard updates, dependency patches, and the security posture an auditor expects to see maintained, not frozen at launch.
Compliance is a standing program, not a one-time line. A standalone HIPAA program costs $30,000 to $120,000 a year to run. Penetration testing, which serious customers and some frameworks expect on a schedule, runs $15,000 to $100,000 per engagement. These recur. They don't appear on a build quote because they aren't part of the build.
Smaller lines add up. Legal review of contracts, terms, and data agreements runs $5,000 to $20,000. An accessibility audit — increasingly required, and the right call regardless — runs another $5,000 to $20,000.
Architecture decides how much of this you pay. Isolate PHI in a dedicated secure vault instead of letting it spread through the application, and you cut long-term maintenance materially — by up to 40 percent in some builds — because every future change touches a smaller, contained surface. The cheapest build and the cheapest five years are rarely the same build. The decisions that lower the five-year number are made in the first month.
A real healthcare software development cost includes the years after launch, not only the sprint that ships v1. A vendor who talks only about build price is either new to healthcare or hoping you won't ask.
How to budget so the number holds
A range becomes a number through discovery, not negotiation. Technical due diligence — settling your data model, your integration scope, and your regulatory class before a contract is signed — is what turns "$80,000 to $500,000" into a figure you can defend to a board. Skip it and you aren't saving time. You're deferring the cost to the point in the project where it's most expensive to absorb.
Discovery should produce three things before anyone signs: a settled regulatory classification, a named integration list with read-only and write-back paths separated, and a compliance scope that states which of HIPAA, SOC 2, 21 CFR Part 11, and IEC 62304 apply. With those settled, the range collapses. Without them, every estimate is a guess wearing a decimal point.
Treat the MVP as a scoping decision, not a discount. A real healthcare MVP narrows what you build first — fewer integrations, fewer roles, one workflow done properly. It does not narrow what you're legally required to do. The moment "MVP" becomes shorthand for skipping HIPAA architecture or deferring validation, you haven't built a smaller product. You've built a liability with a demo attached.
The largest hidden cost in healthcare software is rework, and rework lives in the seam between engineering and QA. When the people writing the code and the people validating it are two separate vendors, the gaps fall into that seam — and surface a week before an audit or submission, when they cost the most to fix.
This is where Flyant works differently. Engineering and quality engineering operate as one function, so validation evidence is built alongside the product instead of reconstructed under deadline. Across 16 years and more than 30 healthcare products, that has meant zero failed regulatory audits and 96 percent of projects delivered on budget — outcomes that come from removing rework, not from quoting low.
A defensible healthcare software development cost starts with discovery, not a price page. If you're scoping a regulated build, start with a discovery engagement before you commit to a number.
Engineering and QA for healthcare teams that can't afford execution risk
Frequently Asked Questions
Didn’t find the answer you are looking for?
Contact usDmitry Reznik is the Chief Technology Officer and co-founder at Flyant, where he leads technology across the full delivery lifecycle, from system architecture to production operations. He brings deep technical expertise in building scalable, high-performance healthcare software with quality engineered in from the start, and he shapes the technical decisions that keep complex systems reliable over time.
